標(biāo)題: Titlebook: Radiation Therapy for Liver Tumors; Fundamentals and Cli Jeffrey Meyer,Tracey Schefter Book 2017 Springer International Publishing AG 2017 [打印本頁(yè)] 作者: Fibromyalgia 時(shí)間: 2025-3-21 19:56
書(shū)目名稱Radiation Therapy for Liver Tumors影響因子(影響力)
書(shū)目名稱Radiation Therapy for Liver Tumors影響因子(影響力)學(xué)科排名
書(shū)目名稱Radiation Therapy for Liver Tumors網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Radiation Therapy for Liver Tumors網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Radiation Therapy for Liver Tumors被引頻次
書(shū)目名稱Radiation Therapy for Liver Tumors被引頻次學(xué)科排名
書(shū)目名稱Radiation Therapy for Liver Tumors年度引用
書(shū)目名稱Radiation Therapy for Liver Tumors年度引用學(xué)科排名
書(shū)目名稱Radiation Therapy for Liver Tumors讀者反饋
書(shū)目名稱Radiation Therapy for Liver Tumors讀者反饋學(xué)科排名
作者: 橫截,橫斷 時(shí)間: 2025-3-21 23:44 作者: 法律 時(shí)間: 2025-3-22 02:25
Assessment of Liver Function: Focus on the ALBI Scoregnosis. Despite extensive and well-recognised limitations, the Child-Pugh score (CPS) is the most widely used grading system. Patients with CPS ‘A’ are optimal for liver-directed therapy and CP ‘C’ are usually excluded for all therapies apart from liver transplantation. The MELD is a statistically d作者: 內(nèi)部 時(shí)間: 2025-3-22 08:01
Radiation Sensitivity of the Liver: Models and Clinical Dataathology of radiation-induced toxicity and normal tissue complication probability (NTCP) modeling with specific focus on the liver. We discuss modeling for both conventional fractionation as well as more recent hypofractionated treatment regimens such as SBRT in cases of metastatic and primary liver作者: 適宜 時(shí)間: 2025-3-22 11:41
Radiation Oncology: Fundamentals and Controversiesn oncology. The recent expansion of the clinical practice of extracranial hypofractionated radiation therapy, made possible by advances in radiation treatment planning and image guidance, has raised an important host of biological questions with immediate clinical implications. In this chapter, we p作者: mastoid-bone 時(shí)間: 2025-3-22 16:58 作者: 無(wú)意 時(shí)間: 2025-3-22 19:06
Principles of Thermal Ablation ablation greatly expanded after the advent of cross-sectional imaging. These techniques are generally used for patients with unresectable and borderline resectable disease, which may be due to the size, number, or location of the liver tumors, or for patients judged inoperable due to the patient’s 作者: Compass 時(shí)間: 2025-3-23 01:01 作者: harpsichord 時(shí)間: 2025-3-23 01:42 作者: 假裝是我 時(shí)間: 2025-3-23 05:51
Yttrium-90 Selective Internal Radiation Therapyry of radioactive microbeads directly into liver tumors via the blood supply. There are presently two devices available to deliver Y90, with different techniques and clinical considerations for the two devices. This therapy requires careful work-up and appropriate patient selection that is best acco作者: 上下連貫 時(shí)間: 2025-3-23 12:30 作者: 預(yù)感 時(shí)間: 2025-3-23 16:16 作者: 開(kāi)花期女 時(shí)間: 2025-3-23 21:28 作者: Sciatica 時(shí)間: 2025-3-24 02:03 作者: Oafishness 時(shí)間: 2025-3-24 04:22
Interstitial Brachytherapy for Liver Tumors: Practical Issuesor liver lesions and appropriate patient selection. We then provide guidance on the technical aspects of treatment planning, needle placement, quality assurance, and radiation dose delivery. Finally, we will review potential advantages and disadvantages of this technique over other liver-directed therapies.作者: eardrum 時(shí)間: 2025-3-24 06:32 作者: BLOT 時(shí)間: 2025-3-24 13:02
Particle Radiation Therapy for Liver Tumors: Simulation and Treatment Planningng and delivery, dose constraints, and carbon therapy. The discussion will primarily focus on proton therapy with some discussion of the utility of carbon therapy. Clinical outcomes of particle therapy will be discussed in separate chapters of this text. The final section of this chapter will be devoted to the future direction of particle therapy.作者: itinerary 時(shí)間: 2025-3-24 16:52
brachytherapy, used to treat liver tumors.Details radiation.The management of liver tumors is a nexus of interactions among multiple medical specialties, including radiation oncology. A multitude of liver-directed therapies are available for patients, ranging from surgery and liver transplantation 作者: 后天習(xí)得 時(shí)間: 2025-3-24 20:56 作者: Immobilize 時(shí)間: 2025-3-25 01:51 作者: 我說(shuō)不重要 時(shí)間: 2025-3-25 03:19
Radiation Sensitivity of the Liver: Models and Clinical Datas. Moreover, we review the confounding role of tolerance dose modifying factors such as cirrhosis and hepatitis viral infection. Finally, we discuss the prospects of including non-dosimetric variables into NTCP models and the role of advanced computational modeling.作者: 是比賽 時(shí)間: 2025-3-25 10:29
Yttrium-90 Selective Internal Radiation Therapytocellular carcinoma, neuroendocrine tumor, with emerging data in other malignancies. This chapter seeks to describe the appropriate patient selection, work-up, technique, dosimetry, complications, and follow-up of Y90 as performed in current clinical practice.作者: 有幫助 時(shí)間: 2025-3-25 15:26
hat have been studied by Simons and his colleagues and place it in a broader paleontological and historical perspective. The volume will contain the results of new research and reviews of many of the critical issues in primate and human evolution during the last half of the twentieth century and wel作者: FLAG 時(shí)間: 2025-3-25 16:08
Jeffrey Meyer MD, MS,Tracey E. Schefter MDhat have been studied by Simons and his colleagues and place it in a broader paleontological and historical perspective. The volume will contain the results of new research and reviews of many of the critical issues in primate and human evolution during the last half of the twentieth century and wel作者: 去才蔑視 時(shí)間: 2025-3-25 21:19
David C. Westerly PhD,Karyn A. Goodman MD, MShat have been studied by Simons and his colleagues and place it in a broader paleontological and historical perspective. The volume will contain the results of new research and reviews of many of the critical issues in primate and human evolution during the last half of the twentieth century and wel作者: Ordeal 時(shí)間: 2025-3-26 04:09 作者: 混合物 時(shí)間: 2025-3-26 07:11
D. Thor Johnson MD, PhD,Adam Leon Kesner PhD? er kennt das Gute und B?se; und jetzt soll er nicht seine Hand ausstrecken und vom Baume des Lebens nehmen und essen und unsterblich sein“. Er schickt den Menschen aus dem Lustgarten fort und stellt die Kerube und das gezückte Flammenschwert auf, ?den Weg zum Lebensbaum zu bewachen“.作者: gerontocracy 時(shí)間: 2025-3-26 12:00
Michael R. Folkert MD, PhD,Brian Hrycushko PhD? er kennt das Gute und B?se; und jetzt soll er nicht seine Hand ausstrecken und vom Baume des Lebens nehmen und essen und unsterblich sein“. Er schickt den Menschen aus dem Lustgarten fort und stellt die Kerube und das gezückte Flammenschwert auf, ?den Weg zum Lebensbaum zu bewachen“.作者: 討人喜歡 時(shí)間: 2025-3-26 16:28
Liver Anatomy and Functionhypertension, i.e. the increased resistance to portal blood flow that creates an increased gradient of pressure between the portal vein and the inferior vena cava. When the portal pressure increases beyond 12?mm Hg, patients are prone to develop ascites, varices, and hepatic encephalopathy. Transjug作者: 吝嗇性 時(shí)間: 2025-3-26 20:19
Surgical Considerationsh after liver surgery and is most commonly seen in patients with cirrhosis. Therefore, surgical resection is limited to cirrhotic patients with Child-Turcotte-Pugh class A and no evidence of significant portal hypertension. The volume of the future liver remnant (FLR) needed to minimize the chances 作者: pulmonary-edema 時(shí)間: 2025-3-26 23:22 作者: diabetes 時(shí)間: 2025-3-27 01:51
External Beam Radiation Therapy for Liver Tumors: Simulation, Treatment Planning, and Advanced Delivfiducial markers for target localization. Conformal planning techniques such as 3D conformal radiation therapy (3DCRT) and volumetric-modulated arc therapy (VMAT) are discussed, as are dose-limiting toxicities and dose constraints for the healthy liver, gastrointestinal tract, and chest wall. Specia作者: 先鋒派 時(shí)間: 2025-3-27 08:52 作者: Servile 時(shí)間: 2025-3-27 12:30
Radiation Therapy for Hepatocellular Carcinoma: Clinical Dataf the clinical data for radiation therapy, including fractionated external beam radiation therapy (EBRT), SBRT, charged particle therapy, brachytherapy, and radioembolization, and discusses results of radiation in various clinical scenarios.作者: FILTH 時(shí)間: 2025-3-27 16:20 作者: 手術(shù)刀 時(shí)間: 2025-3-27 21:06 作者: paradigm 時(shí)間: 2025-3-28 00:30
Erqi L. Pollom MD,Yushen Qian MD,Julie L. Koenig BS,Albert C. Koong MD, PhD,Daniel T. Chang MD作者: misshapen 時(shí)間: 2025-3-28 02:16 作者: 進(jìn)入 時(shí)間: 2025-3-28 09:19
will contain the results of new research and reviews of many of the critical issues in primate and human evolution during the last half of the twentieth century and wel978-1-4419-2536-7978-0-387-73896-3Series ISSN 1574-3489 Series E-ISSN 1574-3497 作者: 無(wú)價(jià)值 時(shí)間: 2025-3-28 11:20 作者: epicondylitis 時(shí)間: 2025-3-28 18:05
Ali A. Haydar MD, MRCP, FRCR,Layla Antoine Nasr MD,Hero K. Hussain MD, FRCR, FACRwill contain the results of new research and reviews of many of the critical issues in primate and human evolution during the last half of the twentieth century and wel978-1-4419-2536-7978-0-387-73896-3Series ISSN 1574-3489 Series E-ISSN 1574-3497 作者: CEDE 時(shí)間: 2025-3-28 20:17
Philip J. Johnson MD, FRCP,Harun Khan MBBS,Sarah Berhane PhDwill contain the results of new research and reviews of many of the critical issues in primate and human evolution during the last half of the twentieth century and wel978-1-4419-2536-7978-0-387-73896-3Series ISSN 1574-3489 Series E-ISSN 1574-3497 作者: 神圣不可 時(shí)間: 2025-3-28 23:42
Issam El Naqa MA, MS, PhD, DABR,Kyle Cuneo MD,Dawn Owen MD, PhD,Theodore S. Lawrence MD, PhD,Randallwill contain the results of new research and reviews of many of the critical issues in primate and human evolution during the last half of the twentieth century and wel978-1-4419-2536-7978-0-387-73896-3Series ISSN 1574-3489 Series E-ISSN 1574-3497 作者: dragon 時(shí)間: 2025-3-29 06:15
will contain the results of new research and reviews of many of the critical issues in primate and human evolution during the last half of the twentieth century and wel978-1-4419-2536-7978-0-387-73896-3Series ISSN 1574-3489 Series E-ISSN 1574-3497 作者: ambivalence 時(shí)間: 2025-3-29 10:49
Ana Luiza Mandelli Gleisner MD, PhDwill contain the results of new research and reviews of many of the critical issues in primate and human evolution during the last half of the twentieth century and wel978-1-4419-2536-7978-0-387-73896-3Series ISSN 1574-3489 Series E-ISSN 1574-3497 作者: irreducible 時(shí)間: 2025-3-29 15:04 作者: 臭名昭著 時(shí)間: 2025-3-29 19:28 作者: Venules 時(shí)間: 2025-3-29 20:26 作者: 清洗 時(shí)間: 2025-3-30 03:09
mentary material: .Elwyn Simons has held professional appointments at Yale University (1960-1977), Duke University (1977-present), and was the Director of the Duke Primate Center (1977-1991) and Scientific Director (1991-2001). He has authored nearly 300 scientific publications and is the holder of 作者: Project 時(shí)間: 2025-3-30 04:58
ate Center (1977-1991) and Scientific Director (1991-2001). He has authored nearly 300 scientific publications and is the holder of many high honors. He is a member of the United States National Academy of Sciences, the American Philosophical Society, as well as many other professional associations.作者: EWE 時(shí)間: 2025-3-30 09:43 作者: medieval 時(shí)間: 2025-3-30 15:59 作者: SOBER 時(shí)間: 2025-3-30 20:33
